Baystate Wealth Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-80
Closed -$2.37K 1329
2023
Q3
$2.37K Hold
80
﹤0.01% 778
2023
Q2
$2.86K Buy
+80
New +$2.3K ﹤0.01% 796
2021
Q1
Sell
-10
Closed -$1K 757
2020
Q4
$1K Buy
10
+9
+900% +$1.04K ﹤0.01% 614
2020
Q3
$0 Buy
+1
New +$91 ﹤0.01% 672

Other funds holding GH

Baystate Wealth Management's GH Position: Q4 2023 in Review

Baystate Wealth Management sold out of Guardant Health (GH) in Q4 2023, closing a stake of 80 shares — an estimated $2.37K sold.

Baystate Wealth Management first reported a position in GH in Q3 2020 and held it in 4 quarters. The position peaked at $2.86K in Q2 2023. 294 funds tracked by Wall St. Rank hold GH as of Q4 2023.

  • Baystate Wealth Management reported no remaining Guardant Health position as of Q4 2023 after selling out during the quarter.
  • Baystate Wealth Management sold 80 Guardant Health shares in Q4 2023, an estimated $2.37K.
  • Baystate Wealth Management first reported a position in Guardant Health in Q3 2020 and held it in 4 quarters.
  • Baystate Wealth Management's Guardant Health position peaked at $2.86K in Q2 2023.
  • 294 funds tracked by Wall St. Rank held Guardant Health as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.